IFNA17 and cytomegalovirus infection: Identification of the association between the specific circulating HCMV-encoded miRNAs and the efficacy of IFNα therapy for individual CHB patients may also provide evidence that HCMV infection can influence the host immune response of CHB patients to IFNα therapy.